Healthcare -
Biotechnology - NASDAQ - US
$ 1.2229
-0.84 %
$ 18.5 M
Market Cap
-0.87
P/E
LGVN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LGVN - Longeveron Inc.
28.8 M
LAST VALUE
665.27%
2 YEAR CAGR
141.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR